MedTrace Logo

A Smartphone Application for Screening of Developmental Disorders in Children

NCT04958174 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2021-12-20

No results posted yet for this study

Summary

The detection of developmental disorders in the child is often late because the parents do not have the information necessary to consult at the first clinical signs. For example, the diagnosis of autism spectrum disorders is made at the age of 5, so earlier diagnoses are possible earlier or even in the 1st year with appropriate questionnaires.

An application (Malo) has been developed to allow through regular questionnaires from 1 month to 3 years old to assess the child's development by his parents in the form of a digital health record assessing several areas at regular intervals (monthly the 1st year then every 3 to 12 months): sensory, psychomotor development, sleep, height and weight, cognitive and addictions (especially to screens). The questions will be adapted to the age of the child. An alert suggesting to consult the general practitioner or the pediatrician will be generated according to an algorithm validated by a committee of experts.

Based on a study model on health data already carried out as part of the triage application for patients suspected of COVID 19 coronavirus disease.fr with 14 million users in 6 months having improved the relevance of calls to the 15 (8 times fewer unnecessary calls) and general practitioners.

This study will assess parental interest in this application.

Conditions

  • Development, Child

Interventions

DEVICE

web-application

web application for monitoring children's development

Sponsors & Collaborators

  • Kelindi

    collaborator INDUSTRY

  • Weprom

    lead OTHER

Principal Investigators

  • Fabrice DENIS, Pr · Weprom

Eligibility

Min Age
1 Month
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-15
Primary Completion
2023-02-15
Completion
2023-02-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04958174 on ClinicalTrials.gov